These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2229448)

  • 1. Globalization of the pharmaceutical industry: opportunities for physicians in clinical research.
    Dziewanowska ZE
    J Clin Pharmacol; 1990 Oct; 30(10):890-2. PubMed ID: 2229448
    [No Abstract]   [Full Text] [Related]  

  • 2. Globalization of the pharmaceutical industry: the physician's role in optimizing drug use.
    Young MD
    J Clin Pharmacol; 1990 Nov; 30(11):990-3. PubMed ID: 2243156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globalization of the pharmaceutical industry: the physician's role in evaluating drug safety.
    Beg MM
    J Clin Pharmacol; 1990 Nov; 30(11):994-6. PubMed ID: 2243157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Going it alone.
    Senior M
    Nat Biotechnol; 2014 May; 32(5):411-4. PubMed ID: 24811507
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical Portfolio & Product Life Cycle Management--SMi's fourth annual conference. 29-30 June 2009, London, UK.
    Beecher N
    IDrugs; 2009 Sep; 12(9):558-60. PubMed ID: 19697274
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy making on data exclusivity in the European Union: from industrial interests to legal realities.
    Adamini S; Maarse H; Versluis E; Light DW
    J Health Polit Policy Law; 2009 Dec; 34(6):979-1010. PubMed ID: 20018988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Marketing of medicinal products in the European Community. The Mutual Recognition and Decentralised Procedures].
    Bachmann P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):722-30. PubMed ID: 18560780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of the Committee for Medicinal Products for Human Use (CHMP) in the European centralised procedure].
    Enzmann H; Schneider C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):731-9. PubMed ID: 18584106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The physician in the pharmaceutical industry. Functions and responsibilities. Historical development, current situation and future perspectives].
    Castillo Pérez P
    Rev Clin Esp; 1986 Sep; 179(4):207-16. PubMed ID: 3764009
    [No Abstract]   [Full Text] [Related]  

  • 10. [EU law on marketing authorization of medicines. History, current state of development and perspectives].
    Nettesheim M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):705-12. PubMed ID: 18560781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of neurologists in the pharmaceutical industry.
    Peroutka SJ
    West J Med; 1994 Sep; 161(3):328-30. PubMed ID: 7975576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenerics standoff.
    Herrera S
    Nat Biotechnol; 2004 Nov; 22(11):1343-6. PubMed ID: 15529145
    [No Abstract]   [Full Text] [Related]  

  • 13. Gray marketing of pharmaceuticals.
    Chaudhry PE; Walsh MG
    J Health Care Mark; 1995; 15(3):18-22. PubMed ID: 10172516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. We are ready for Brexit, say drugs companies.
    Vet Rec; 2019 Mar; 184(12):362. PubMed ID: 30902928
    [No Abstract]   [Full Text] [Related]  

  • 15. 'We're not worried' about no-deal Brexit.
    Vet Rec; 2019 Feb; 184(5):134-135. PubMed ID: 30705197
    [No Abstract]   [Full Text] [Related]  

  • 16. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmaceutical industry and academic medicine: opportunities for physician collaboration.
    Jefferis JE
    Circulation; 1985 Aug; 72(2 Pt 2):I21-4. PubMed ID: 3924438
    [No Abstract]   [Full Text] [Related]  

  • 18. Centre proposes limited use of drugs before phase III trials to speed innovation.
    Hawkes N
    BMJ; 2013 Mar; 346():f1824. PubMed ID: 23516255
    [No Abstract]   [Full Text] [Related]  

  • 19. Academic physicians confront a hostile world: the creation of ACRE.
    Weber MA
    J Clin Hypertens (Greenwich); 2009 Oct; 11(10):533-6. PubMed ID: 19817932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Marketing authorization for pharmaceuticals: the necessity of European collaboration].
    Seitz R; Enzmann H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):703-4. PubMed ID: 18592336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.